SLCO1B1 and diabetes mellitus: The frequency of DGI as recently reported for CYP2D6, CYP2C19 and SLCO1B1 [45] further implies that a significant proportion of persons with diabetes will have phenotypes for which actions in principle should be taken regarding dose adjustment or avoidance of the given drugs.